CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 9,182 Value ($000) $308 Avg Close $37.35 Range $31.65 - $53.55
Q2 2024
Shares 141,204 Value ($000) $6,325 Avg Close $46.18 Range $41.01 - $53.70
Q3 2023
Shares 29,500 Value ($000) $877 Avg Close $20.61 Range $15.76 - $31.00
Q4 2021
Shares 445 Value ($000) $12 Avg Close $24.65 Range $18.97 - $28.82
Q1 2020
Shares 4,246 Value ($000) $62 Avg Close $20.50 Range $10.63 - $26.67
Q3 2019
Shares 55,112 Value ($000) $829 Avg Close $19.45 Range $14.33 - $26.27
Q2 2019
Shares 34,238 Value ($000) $857 Avg Close $24.76 Range $21.27 - $28.80
Q1 2019
Shares 34,062 Value ($000) $775 Avg Close $24.58 Range $21.05 - $30.61